Bruker PT Raised to $27.50 (BRKR)
Equities research analysts at Cowen and Company increased their price objective on shares of Bruker (NASDAQ:BRKR) from $25.00 to $27.50 in a research note issued to investors on Tuesday. Cowen and Company’s price target suggests a potential upside of 11.97% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at Wells Fargo & Co. upgraded shares of Bruker from a “market perform” rating to an “outperform” rating in a research note on Thursday, June 19th. Analysts at ISI Group cut their price target on shares of Bruker to $24.50 in a research note on Thursday, May 8th. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Bruker currently has a consensus rating of “Buy” and an average price target of $24.90.
Bruker (NASDAQ:BRKR) traded up 1.19% on Tuesday, hitting $24.56. The stock had a trading volume of 644,229 shares. Bruker has a 1-year low of $15.41 and a 1-year high of $24.93. The stock has a 50-day moving average of $22.04 and a 200-day moving average of $21.59. The company has a market cap of $4.114 billion and a price-to-earnings ratio of 48.64.
Bruker (NASDAQ:BRKR) last announced its earnings results on Wednesday, May 7th. The company reported $0.11 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.09 by $0.02. The company had revenue of $423.70 million for the quarter, compared to the consensus estimate of $402.04 million. During the same quarter in the prior year, the company posted $0.08 earnings per share. The company’s quarterly revenue was up 7.7% on a year-over-year basis. On average, analysts predict that Bruker will post $0.88 earnings per share for the current fiscal year.
Bruker Corporation (NASDAQ:BRKR) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.